Agent for controlling Bcl-2 expression comprising ginsenoside F1 as an active component
US8258272B2 · kind B2 · utility
1Cited by
2References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 9, 2008 |
| Grant date | Sep 4, 2012 |
| Priority date | — |
| Expiry date | Jun 9, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an agent for controlling Bcl-2 expression comprising ginsenoside F1 (20-O-β-D-glucopyranosyl-20(S)-protopanaxatriol) represented by the following formula 1 as an active component.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.